We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

37 hedge funds and large institutions have $13.6M invested in Checkpoint Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

0.14% less ownership

Funds ownership: 1.91% → 1.77% (-0.14%)

8% less funds holding

Funds holding: 40 → 37 (-3)

18% less capital invested

Capital invested by funds: $16.6M → $13.6M (-$2.94M)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$545K
2
State Street
State Street
Massachusetts
+$158K
3
PAS
Park Avenue Securities
New York
+$148K
4
Wells Fargo
Wells Fargo
California
+$107K
5
Squarepoint
Squarepoint
New York
+$54.1K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$810K
2
Millennium Management
Millennium Management
New York
-$124K
3
Jane Street
Jane Street
New York
-$95K
4
Deutsche Bank
Deutsche Bank
Germany
-$90.5K
5
VOYA Investment Management
VOYA Investment Management
Georgia
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$18K +$13.7K +500 +204%
Deutsche Bank
27
Deutsche Bank
Germany
$16K -$90.5K -3,298 -83%
SO
28
STRS Ohio
Ohio
$15K – – –
Bank of America
29
Bank of America
North Carolina
$12K -$137 -5 -1%
Victory Capital Management
30
Victory Capital Management
Texas
$11K +$12.5K +456 New
Legal & General Group
31
Legal & General Group
United Kingdom
$10K – – –
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$8K -$3.76K -137 -28%
TRCT
33
Tower Research Capital (TRC)
New York
$6K -$3.81K -139 -36%
AIP
34
Ameritas Investment Partners
Nebraska
$5K – – –
Citigroup
35
Citigroup
New York
$3K -$14.4K -525 -81%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$2.79K +$2.91K +106 +1,767%
MAM
37
Meeder Asset Management
Ohio
$2K +$1.89K +69 New
Millennium Management
38
Millennium Management
New York
– -$124K -4,091 Closed
Jane Street
39
Jane Street
New York
– -$95K -3,152 Closed
VOYA Investment Management
40
VOYA Investment Management
Georgia
– -$51K -1,686 Closed
VF
41
Virtu Financial
New York
– -$49K -1,606 Closed
ARTA
42
A.R.T. Advisors
New York
– -$45K -1,492 Closed
Stifel Financial
43
Stifel Financial
Missouri
– -$33K -1,059 Closed
SKK
44
Shepherd Kaplan Krochuk
Massachusetts
– -$30K -1,000 Closed
Federated Hermes
45
Federated Hermes
Pennsylvania
– -$4K -117 Closed
1
2

CKPT Hedge Fund Activity: Q3 2019 in Review

37 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2019, worth a combined $13.6M — down 18% from $16.6M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CKPT and 5 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 15 added.

The largest buyer was Northern Trust, adding an estimated $545K. The largest seller was BlackRock, cutting an estimated $810K.

  • 37 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2019, down from 40 in Q2 2019.
  • Funds reported $13.6M of Checkpoint Therapeutics stock for Q3 2019, down 18% quarter-over-quarter.
  • 5 funds opened new Checkpoint Therapeutics positions in Q3 2019 and 8 closed out, a net change of -3 holders.
  • The largest Checkpoint Therapeutics buyer in Q3 2019 was Northern Trust, an estimated $545K added.
  • The largest Checkpoint Therapeutics seller in Q3 2019 was BlackRock, an estimated $810K sold.

Based on aggregated 13F filings for Q3 2019.